Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in the last 6 Months for Innovative Medicines Canada/Médicaments novateurs Canada

Bettina Hamelin, President and CEO (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 46

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jagsharan Singh Mahal , Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2025-12-09
    Posted date: 2026-01-12
    Communication number: 371-665160 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jocelyne Voisin , Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-08
    Posted date: 2026-01-12
    Communication number: 371-665156 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Justine Frame, Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Deputy Chief of Staff and Director of Policy to the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-02
    Posted date: 2026-01-12
    Communication number: 371-665151 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Martin Moen, Associate Asst Dep. Minister, Trade Policy and Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-02
    Posted date: 2026-01-12
    Communication number: 371-665147 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karim Bardeesy, Member of Parliament, and Parliamentary Secretary to the Minister of Industry | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-02
    Posted date: 2026-01-12
    Communication number: 371-665146 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Advisor to Canada’s Minister of Industry | Innovation, Science and Economic Development Canada (ISED)
    • Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-02
    Posted date: 2026-01-12
    Communication number: 371-665144 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Galen Richardson, Director of Stakeholder Relations, Office of President of the King’s Privy Council for Canada and Minister Responsible for Canada- U.S. Trade, Intergo | Privy Council Office (PCO)
    • Nasser Haidar, Senior Policy Advisor | Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Intergovernmental Affairs Secretariat (IGA)
    • Miro Froehlich, Director of Policy | Office of the President of the King's Privy Council for Canada, Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs, Internal Trade | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-01
    Posted date: 2026-01-12
    Communication number: 371-665132 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter M. Boehm, Senator | Senate of Canada

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-01
    Posted date: 2026-01-12
    Communication number: 371-665125 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Acting Director General | Life Sciences | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2025-10-22
    Posted date: 2025-11-12
    Communication number: 371-654924 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-22
    Posted date: 2025-11-12
    Communication number: 371-654920 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mackenzy Metcalfe, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-13
    Communication number: 371-655507 (amended from 371-654902) View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karina Gould, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654917 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Senior Policy Advisor, Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654908 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maggie Chi, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654890 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Deputy Chief of Staff and Director of Policy to the Minister of Health | Health Canada (HC)
    • Jade Mallette, Chief of Staff, Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654881 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Policy Advisor, Office of the Minister Innovation, Science and Economic Development Canada (ISED | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy, Office of the Minister Innovation, Science and Economic Development Canada (ISED) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654865 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hosai Zurmati Halim, Senior Policy Advisor, Office of the President, Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)
    • Elizabeth Wong, Policy Advisor, Office of the Minister, Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Scott Reid, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Iris Petten, Senator | Senate of Canada

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654833 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandra Pupatello, Senator | Senate of Canada

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654829 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Miro Froehlich, Director of Policy, Office of the Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654810 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654808 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anna Roberts, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654805 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Parm Bains, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654803 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Bittle, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654799 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Strauss, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654795 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Acting Director General | Life Sciences | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654789 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daryl Fridhandler, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654787 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654785 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jocelyne Voisin , Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654779 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Loffreda, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654775 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maxime Blanchette-Joncas, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654771 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Charles Sousa, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654768 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654765 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kurt Holman, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654760 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Burton Bailey, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654757 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Brendan Hanley, Member of Parliament | House of Commons
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654753 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Xie, Senior Policy Advisor to the Secretary of State, International Development | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654744 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-21
    Posted date: 2025-11-12
    Communication number: 371-654740 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jocelyne Voisin , Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, Internal Trade, International Relations, International Trade, Science and Technology, Taxation and Finance, National Security/Security, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-10-06
    Posted date: 2025-11-12
    Communication number: 371-654734 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Hébert, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology, Taxation and Finance, Research and Development
    Communication date: 2025-09-11
    Posted date: 2025-10-09
    Communication number: 371-648889 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Lisa Xie, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic, Senior Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Infrastructure, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2025-09-11
    Posted date: 2025-10-09
    Communication number: 371-648869 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Pamela Aung-Thin , Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Intellectual Property, Science and Technology, Taxation and Finance, Research and Development
    Communication date: 2025-09-09
    Posted date: 2025-10-09
    Communication number: 371-648864 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matthew Hall, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-08-26
    Posted date: 2025-09-09
    Communication number: 371-645097 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Galen Richardson, Senior Advisor, Stakeholder Relations for Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian | Privy Council Office (PCO)
    • Miro Froehlich, Director of Policy, for Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Privy Council Office (PCO)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Relations, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-08-06
    Posted date: 2025-09-09
    Communication number: 371-645096 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mackenzy Metcalfe, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-07-30
    Posted date: 2025-08-13
    Communication number: 371-642589 View monthly communication report
Date Modified: